Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vascular Disease: early-phase trial registry
2 of 11 indexed Vascular Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 2 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Vascular Disease: 11 US clinical trials tracked, 2 recruiting.
Vascular Disease is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Michael Murphy, running 1 of these trials.
Enrollment posture brief
Registry condition vascular-disease
OPEN 2 | RECR 18% | LATE 0 | EARLY 3 | RANK #1577 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (18% recruiting · 22 trials)
Vascular Disease lists 2 open slots (18% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vascular Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vascular Disease is recruiting below its size-band peers.
2 of 11 indexed trials (18.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Vascular Disease trials is spread across many organizations.
Michael Murphy accounts for 1 of 11 trials (9.1%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Vascular Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 86 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.
-
Vascular Disease splits between interventional and observational designs.
5 interventional and 6 observational studies make up this index (45.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
W.L.Gore & Associates
NCT06658730
Studies of Neuregulin/ERBB Signaling in Human Heart
Douglas B. Sawyer
NCT02820233
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
Abbott Medical Devices
NCT01120379
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Cordis US
NCT01355406
Study of Abnormal Blood Clotting in Children With Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001927
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
University of Illinois at Chicago
NCT02776566
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Indiana University
NCT02685098
Effect of Diet on Vascular Disease in Pre-Menopausal Women
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00484861
Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet
Cedars-Sinai Medical Center
NCT02065648
Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)
Michael Murphy
NCT02863926
Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)
US Department of Veterans Affairs
NCT00038285
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Vascular Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vascular Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vascular Disease page
11 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Vascular Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Michael Murphy sponsors the most Vascular Disease trials on record, review their full trial history before evaluating a specific study. See Michael Murphy's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular Disease condition card totals 11 registered trials; most-linked intervention Patient Self-Monitoring vs Anticoagulation Clinic; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.